Shuttle Pharmaceuticals Holdings, Inc. Announces Appointment of Chris Senanayake, PhD To Board of Directors
Share this article Share this article ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc., (Shuttle Pharma) a clinical stage company developing drugs to improve the treatment of cancer patients undergoing radiation therapy is pleased to announce the addition of Chris Senanayake, PhD as a member of its Board of Directors. Shuttle Pharma believes Dr. Senanayake is uniquely qualified to serve as a board member because of his vast experience and expertise in the pharmaceuticals industries. Dr. Senanayake has more than 30 years of pharmaceutical industry experience...